Navigation Links
CareFusion Expands Skin Antisepsis Portfolio

SAN DIEGO, Sept. 27 /PRNewswire/ -- CareFusion (NYSE: CFN), a leading, global medical device company, has announced it has entered into an agreement with Healthpoint, Ltd. to market and sell innovative surgical scrub solutions, including Surgicept® Waterless Surgical Hand Scrub, Triseptin® Water-Aided Surgical Scrub and Triseptin® Hand and Body Antiseptic.



The license agreement gives CareFusion exclusive rights to sell the products in the United States (U.S.). With the addition of these products to its infection prevention product portfolio, which includes the patient preoperative skin antiseptic ChloraPrep® (2 percent chlorhexidine gluconate/70 percent isopropyl alcohol) and surgical clippers, CareFusion now offers a more comprehensive package of clinically proven products and technologies to help reduce the risk of health care-associated infections (HAIs) related to surgical procedures.

It has been established that HAIs can be reduced with proper hand antisepsis by health care professionals prior to surgery, which limits the transfer of potentially harmful microorganisms to the skin of their patients.(1) Recommendations and guidelines, including those from the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), state that health care professionals should clean their hands with an alcohol-based antimicrobial solution prior to patient contact or putting on gloves. However, adherence to these guidelines is lower than it should be; studies have shown an average compliance rate of 40 percent.(1) According to the CDC, poor compliance is due to multiple factors, including perceived lack of time and irritation or dryness caused by the antiseptic.

"To reduce the risk of infection, clinical evidence and practice recommendations clearly state the importance of disinfecting the patient's and the health care professional's skin prior to any surgical procedure," said Jason Strohm, vice president and general manager, CareFusion Infection Prevention. "With ChloraPrep for patient skin and Surgicept for the hands of surgical health care workers, we now offer a comprehensive line of clinically proven products to help reduce the risk of HAIs at their source: the skin."  

Meeting Customer Needs

A recently conducted study of health care professionals showed the ingredients and formulation of Surgicept may address some of the factors related to the failure to adhere to surgical hand scrub protocols. In this study, OR health care professionals were blindfolded and asked to separately apply two different waterless surgical hand hygiene products, Surgicept® Waterless Surgical Hand Scrub and Avagard® Surgical Hand Antiseptic, and rate them on a series of attributes. Nearly 80 percent of the surgeons and OR staff preferred Surgicept to Avagard, the current leading waterless surgical hand antiseptic.(2) Participants found Surgicept to be significantly more appealing and noted its soft, smooth feel and quick drying time. In addition to overall preference, more participants favored Surgicept on specific attributes that could have a positive effect on compliance, including easier gloving, quicker dry time, less residue on the skin and an easier application process.

"We developed the Surgicept formulation to address the complaints from surgical staff about the feel, longer drying time and stickiness of current surgical scrub products," said Shanta M. Modak, Ph.D., research scientist, Columbia University Medical Center, New York, NY and inventor of Surgicept. "I believe that Surgicept will make hand hygiene more comfortable for health care professionals and therefore has the potential to increase compliance."

Acquired by Healthpoint in October 2005, Surgicept offers health care professionals a waterless, brushless, effective and convenient surgical hand scrub. It doesn't leave a sticky residue, goes on easily, dries quickly and feels smooth on the skin – characteristics that surgeons and OR staff say they want in a surgical scrub.

"When we introduced Surgicept more than four years ago, we knew we had an excellent product that met clinicians' needs," said Travis Baugh, Healthpoint President and COO. "With CareFusion's portfolio of outstanding products, and depth and breadth of its sales force, more hospitals and health care professionals will have easy access to the benefits of Surgicept."

About Surgicept®

Surgicept is an effective waterless surgical hand antiseptic. Its unique patented formulation is proven to meet and exceed FDA requirements for surgical hand scrubs. Surgicept kills 99.99 percent of bacteria in vitro in 15 seconds and requires only a two minute scrub protocol.(3) Surgicept dries quickly and unlike other surgical scrubs, it leaves no sticky, tacky build up or greasy residue, which makes it easier to glove and eliminates glove slippage or the need to towel dry. The unique, patented formulation of Surgicept also includes emollients to counter the drying affects of alcohol.

About Triseptin®

Triseptin Water Aided Surgical Scrub and Triseptin Hand and Body Antiseptic are alcohol-based antiseptics that work with water to remove dirt and microorganisms when used prior to surgical procedures. Triseptin Water-Aided Surgical Scrub can be used with a brush or water alone, providing skin-conditioning benefits and antimicrobial protection. Triseptin Hand and Body Antiseptic, when used twice before surgery per label instructions, significantly reduces the number of microorganisms on the skin.

About ChloraPrep®

ChloraPrep patient preoperative skin preparation - a combination of 2 percent chlorhexidine gluconate and 70 percent isopropyl alcohol - is a proven antiseptic designed to prepare patients' skin for a broad range of major and minor surgical procedures by reducing the number of microorganisms on the skin.  The efficacy and safety of ChloraPrep for skin antisepsis are supported by more than 35 clinical studies and recommendations by 18 internationally recognized organizations or guidelines, including 11 that specifically recommend 2 percent chlorhexidine – a key ingredient in ChloraPrep.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve patient care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AirLife™, AVEA® and LTV® series of ventilators and respiratory products, ChloraPrep® skin prep products, MedMined™ services for infection surveillance, V. Mueller® and Snowden-Pencer® surgical instruments and NeuroCare diagnostic products. CareFusion employs more than 15,000 people across its global operations. More information may be found at

(1) CDC. Morbidity and Mortality Weekly Report: Guideline for Hand Hygiene in Health-Care Settings. October 25, 2002, Vol. 51, No. RR-16.

(2) Surgical Scrub Comparison Quantitative Market Research. Bernstein-Rein, 2010.

(3) Surgicept Technical Bulletin on file, CareFusion Corporation.

SOURCE CareFusion Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition
2. CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
3. CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010
4. CareFusion Shipping Ventilators to CDC for National Emergency Preparedness
5. CareFusion Moves First Quarter Earnings Announcement to November 5
6. CareFusion Announces 5-Year, Sole Source Pyxis(R) Perioperative Solutions Agreement With CHRISTUS Health
7. CareFusion Reports First Quarter Results, Raises Full-Year Outlook
8. CareFusion Signs Exclusive Partnership Agreement With Minimally Invasive Devices to Distribute FloShield Laparoscopic Technology
9. CareFusion Signs Multi-Year Technology Licensing Agreement for Masimo Rainbow SET(R) Pulse CO-Oximetry(TM)
10. CareFusion Will Host an Earnings Conference Call on Feb. 9 to Discuss the Results for the Second Quarter of Fiscal 2010
11. FDA Lifts Injunction on Manufacture and Sale of CareFusion Alaris(R) SE Pump
Post Your Comments:
(Date:11/30/2015)... MOUNTLAKE TERRACE, Wash. and ST. ... Cross and Express Scripts (NASDAQ: ESRX ) today ... benefit agreement. The partnership, which began in 1999, will ... --> --> After evaluating pharmacy ... process, Premera concluded that Express Scripts continues to offer ...
(Date:11/30/2015)... CHICAGO , Nov. 30, 2015   Nuance ... The National Decision Support Company (NDSC) today ... support and collaboration capabilities that utilize the American College ... and healthcare provider organizations to comply with current ... --> --> By combining clinical ...
(Date:11/30/2015)... , Nov. 30, 2015 Varian Medical Systems (NYSE: ... an educational partnership with Apollo Hospitals Group, the largest hospital chain ... will help train radiation technologists in the country. The MoU was ... Apollo Knowledge, and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... , ... According to Los Angeles bariatric surgeon Michael Feiz, M.D., F.A.C.S., many ... real hunger, but instead by a hormone called ghrelin which (often prematurely) signals ... are aware that weight loss surgery can help patients lose weight by restricting the ...
(Date:11/30/2015)... Miami, FL (PRWEB) , ... November 30, 2015 ... ... added a comparison chart and ingredient list of its hemorrhoid ointment to its ... “fast, effective pain relief for people suffering from hemorrhoids. Adding the comparison chart ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood sugar tests ... adults, according to a new study by researchers at the School of Public Health ... Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in Public Health, ...
(Date:11/30/2015)... ... November 30, 2015 , ... The recently ... Poison Data System (NPDS) reveals that in 2014, someone called a poison center ... two million of which were human exposure cases. , The American Association of ...
(Date:11/30/2015)... Reading, PA (PRWEB) , ... November 30, 2015 ... ... Ashland Specialty Ingredients (ASI) as their exclusive channel partner for the Nutraceutical Specialties ... supplements markets in the US, effective immediately. , “We are pleased to ...
Breaking Medicine News(10 mins):